VGM & ASSOCIATESHealthcare MSO
Full Menu Search

Navigating the Fast-Paced News Cycle: Key Updates for Our Industry

Published in Government Relations on March 06, 2025

By: Ike Isaacson

As we move into the new year, the headlines are coming at us fast and furious. The constant stream of information from Washington, D.C. can be overwhelming and often confusing. Topics such as tariffs, budgets, and DOGE dominate the news, making it feel like a game of "follow the bouncing ball." 

Amidst this incessant back and forth, it is easy to become desensitized to the continuous stream of orders and changes. However, our industry must remain focused on our priorities. We need to sift through the daily news to identify the items that will have the most significant impact on us. Staying vigilant and up to date is crucial. 

To that end, here are a few key issues to watch: 

DME Relief Act (75/25 Non-Rural Medicare Blended Rate) 

Currently, this relief will not be included in the March package. In fact, it is uncertain whether there will be a package at all. With the House having passed a resolution for the "One Bill" budget, the focus has shifted to meeting the savings obligations outlined in that document. As industry advocates, we must now turn our attention to working with the 119th Congress. This involves securing champions, some of whom may be new, for our 75/25 Blended Rate request. With Senator John Thune now in a Senate leadership position, we are seeking a new champion in that chamber. Our advocacy partners are helping us identify these champions and begin our efforts anew. 

Simultaneously, there is a concerted effort to pursue administrative changes. Our partners at the American Association for Homecare have established strong relationships within CMS, and we are supporting their efforts to secure the much-needed DME relief. 

Regardless of the path we take, we need the voices and actions of our State Associations and every member of the industry. This is a full-court press, and we need everyone to join the fight.

Tariffs 

The administration's recent memorandum setting tariffs on goods from Canada, Mexico, and China has sparked considerable conversation, confusion, and concern within the DMEPOS industry. As details emerge about which products will be affected, VGM has requested an exemption for medical devices. Our industry is known for providing quality service and equipment with significant cost savings compared to facility-based care. By promoting aging in place, we help keep people healthy at a fraction of the cost of other settings. We urge you to contact your Congressperson and request that our products remain exempt from the potential cost increases associated with tariffs. 

Custom Rehab Technology 

VGM is collaborating with our partners at NCART to create a more streamlined and efficient repair and prior authorization process for our CRT providers. While this is currently a state-by-state effort, there is some federal-level discussion regarding the "right to repair." VGM is working with Senator Tammy Duckworth (D-IL) to ensure that our provider community's voice is heard in this discussion. 

Senator Duckworth and Senator Marsha Blackburn (R-TN) have introduced S. 247, the Titanium/Carbon Fiber Bill. This bill allows consumers to choose and pay for custom upgrades without adding to Medicare expenses. A corresponding House bill (H.R. 1703) has been introduced by Representatives John Joyce (R-OH) and Vern Buchanan (R-FL). This bill mirrors the Senate bill's language, facilitating smoother passage through committees and on the floor. We will continue to advocate for this consumer-focused bill and ask our members to do the same. 

HHS Rescinds policy on Public Participation in Rule Making  

Newly minted HHS Director Robert Kennedy released a notice that the department will be rescinding the public participation in rule making policy. In short, this means that the department no longer must release potential changes to rules for public comment. The Administrative Procedure Act (APA) allows a department to exercise this waiver in “matters relating to agency management or personnel or to public property, loans, grants, benefits, or contracts.” It also allows the agency to forgo these requirements for “good cause” when the agency finds that the procedures are “impracticable, unnecessary, or contrary to the public interest.” 

The implications of this decision could have significant impact on the DME Industry. VGM will be monitoring notices and information coming from HHS as rules can be made and released now with little to no public input or knowledge. While the impact of this decision is yet to be seen, it is imperative that the industry continue to demand transparency and disclosure form the administration. 

As always, your VGM Government Team is working diligently on your behalf. We have been traveling the country to meet with you and your congressional staff, as well as traveling to D.C. to meet face-to-face with our congressional champions. Your voice is vital, and we encourage you to share your stories. We are here to support you in hosting on-site visits with your legislators and their staff. Building local relationships is key to our success, and your stories and experiences in serving people in their homes will highlight the important work you do. 

Together, we must continue to fight for those we serve, for our industry, and for each other. Together, we can be Champions of Change. 

Get Connected

Stay up-to-date on the latest resources and news provided by VGM & Associates.

Sign Up for Email

From Our Experts

Proposed Rule Suggests Significant Change To Accreditation Process thumbnail Proposed Rule Suggests Significant Change To Accreditation Process The recently released proposed rule CMS-1828-P contains a significant change that could reshape how suppliers navigate accreditation. The rule proposes a major change that would require suppliers to be surveyed and reaccredited annually instead of the current three (3) year cadence. This proposal raises substantial questions about both operational feasibility and cost implications. August Of Action: Your Chance To Connect With Congress thumbnail August Of Action: Your Chance To Connect With Congress It's time to take advantage of August Of Action—a perfect opportunity to make your voice heard. Every summer, federal legislators return to their home states during the Congressional recess. While it gives them a break from Washington D.C., it's primarily a time for them to connect with constituents like you. HR1 Passes House, Advances to President Trump's Desk for Signature thumbnail HR1 Passes House, Advances to President Trump's Desk for Signature After extensive negotiations and partisan debate, the House has officially passed HR1, clearing the path for the bill to be signed into law by President Donald Trump. The legislation, which aims to reduce federal healthcare expenditures, contains several provisions that may impact the durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) industry. CMS files the Proposed Rule that sheds light on the next round of the Competitive Bidding Program thumbnail CMS files the Proposed Rule that sheds light on the next round of the Competitive Bidding Program On June 30, 2025, CMS filed the anticipated Proposed Rule that includes updates to the Competitive Bidding Program (CBP). Public comments are due 60 days from June 30, 2025. Below is a high-level summary of the rule. It is critical to note that, according to the Proposed Rule Fact Sheet dated June 30, 2025, CMS has stated that they have not announced the specific product categories they are bidding or the specific timeframe for the next competition. Those specifics will be forthcoming in a fu Senate Narrowly Passes HR1, Sending It Back to House for Final Approval thumbnail Senate Narrowly Passes HR1, Sending It Back to House for Final Approval President Donald Trump's sweeping legislative package, formally titled the One Big, Beautiful Bill Act, now referred to as HR1., cleared the Senate today in a dramatic 51–50 vote, with Vice President JD Vance casting the tie-breaking vote. The bill now returns to the House, where lawmakers must decide whether to adopt the Senate's revised version or negotiate further changes before it can reach the president's desk. Several Prominent Medicaid Provisions in Senate's Budget Bill Deemed in Violation of Byrd Rule thumbnail Several Prominent Medicaid Provisions in Senate's Budget Bill Deemed in Violation of Byrd Rule Senate Parliamentarian Elizabeth MacDonough advised this week that multiple Medicaid provisions in the Senate's reconciliation bill would violate Senate procedure by violating the Byrd Rule. The Byrd Rule is a Senate-specific procedural process that allows Senators to prevent or block inclusion of extraneous provisions in reconciliation bills. Other provisions are still under review. Evaluating the Value of a Payer Contract thumbnail Evaluating the Value of a Payer Contract In our last article, Key Payers Denied Your Application Citing Their Network Is Closed – Now What?, we discussed strategies for addressing payer contracting denials due to a closed network. As indicated, this process can be an extremely time-consuming exercise with no guarantees and mixed results. Below are a few things to consider as you evaluate whether a contract is worth the extra effort. Webinar: Webinar: "Navigating The New CMS Landscape: RADs, HMVs, and Supplier Survival" on June 25 at 1 p.m. CT. The Centers for Medicare & Medicaid Services (CMS) has released its final National Coverage Determination (NCD) for RADs and HMVs used in treating chronic respiratory failure due to COPD. While the rule potentially expands access to bilevel ST therapy (RADs), it also introduces complex compliance requirements, tighter usage criteria, and increased documentation burdens—without additional reimbursement.

Give your business an advantage over the competition.

Become a Member